Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.
Press releases published on September 8, 2025
September 8, 2025
MARKETER Releases Comprehensive Digital Marketing Report for E-Commerce & Retail Brands
Indeterminate
EIN Presswire
September 8, 2025
Maia Benson, FlavorCloud Chief Business Officer, Named Recipient of 2025 Women in Supply Chain Award
Indeterminate
EIN Presswire
September 8, 2025
The Game Development Strategy Guide celebrated by early reviewers; selected by Kirkus Reviews for an indie spotlight
Indeterminate
EIN Presswire
September 8, 2025
Voxtur Announces Cease Trade Order and Notice of Default
Indeterminate
GlobeNewswire
September 8, 2025
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
Indeterminate
GlobeNewswire
September 8, 2025
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
Indeterminate
GlobeNewswire
September 8, 2025
Diginex Announces Completion of Eight to One Stock Split Paid as Bonus Shares
Indeterminate
GlobeNewswire
September 8, 2025
Kleen HY-DRO-GEN INC. Announces Commencement of Trading
Indeterminate
GlobeNewswire
September 8, 2025
Computer Resources of America Named to the 2025 Inc. 5000 List of Fastest-Growing Private Companies in America
Indeterminate
GlobeNewswire
September 8, 2025
DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors
Indeterminate
GlobeNewswire
September 8, 2025
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
Indeterminate
GlobeNewswire
September 8, 2025
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
Indeterminate
GlobeNewswire
September 8, 2025
PharmAla Completes Import of LaNeo MDMA for US Distribution
Indeterminate
GlobeNewswire
September 8, 2025
CompoSecure to Move Stock Exchange Listing to NYSE
Indeterminate
GlobeNewswire
September 8, 2025
Rapport Announces Proposed Public Offering of Common Stock
Indeterminate
GlobeNewswire
September 8, 2025
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
Indeterminate
GlobeNewswire
September 8, 2025
Abivax Presents First Half 2025 Financial Results
Indeterminate
GlobeNewswire